Oxcarbazepine

奥卡西平

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameOxcarbazepine
Drug Alias NameOxcarbazepinum氧卡巴氮平OxcarbazepinaOxacarbazepineEpilexter +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsSchizophreniaSeizuresEpilepsies, Partial +[5] 
Global Approved IndicationsSeizures
Approved Indications in ChinaSeizures
Original Approved Country/TerritoryUnited States
Original Approved Date2000/01/14
Country/TerritoryBulgariaCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Schweiz AgNovartis Pharma Ag
Inactive CompaniesSupernus Pharmaceuticals IncDesitin Arzneimittel GmbhQueen Mary University Of London +[7] 
Active IndicationsSeizures
Inactive IndicationsSchizophreniaEpilepsies, PartialEpilepsy +[4] 

Other Information

ATC CodeN03AF02
Related LinksWikipediaDrugBankKEGG